AquaBounty Technologies, Inc. (NASDAQ:AQB – Get Rating) Director Michael K. Stern purchased 15,000 shares of AquaBounty Technologies in a trade that took place on Monday, June 13. The shares were acquired at an average cost of $1.60 per share, for a total transaction of $24,000.00. Following completion of the transaction, the administrator now directly owns 15,000 shares of the company, valued at $24,000. The transaction was disclosed in a filing with the SEC, which is available at this link.
NASDAQ:AQB fell $0.06 during midday trading on Monday, hitting $1.60. 981,231 shares of the company were traded, compared to its average volume of 1,089,372. The company has a fifty-day moving average of $1.50 and a 200-day moving average of $1.77. AquaBounty Technologies, Inc. has a 12-month low of $1.13 and a 12-month high of $6.37. The company has a current ratio of 43.90, a quick ratio of 43.50 and a debt ratio of 0.04.
AquaBounty Technologies Inc (NASDAQ:AQB – Get Rating) last announced its results on Thursday, May 5. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.01. AquaBounty Technologies posted a negative return on equity of 10.71% and a negative net margin of 1,128.26%. On average, research analysts predict that AquaBounty Technologies, Inc. will post -0.39 earnings per share for the current fiscal year.
Several hedge funds have recently changed their positions in AQB. Vanguard Group Inc. increased its equity stake in AquaBounty Technologies by 70.3% in the first quarter. Vanguard Group Inc. now owns 3,764,084 shares of the company valued at $7,039,000 after purchasing an additional 1,553,646 shares during the period. Renaissance Technologies LLC acquired a new position in shares of AquaBounty Technologies in the fourth quarter worth approximately $1,990,000. BNP Paribas Arbitrage SA increased its equity stake in AquaBounty Technologies by 4,619.8% in the fourth quarter. BNP Paribas Arbitrage SA now owns 675,873 shares of the company valued at $1,419,000 after purchasing an additional 661,553 shares during the period. Epiq Partners LLC increased its equity stake in AquaBounty Technologies by 89.8% in the fourth quarter. Epiq Partners LLC now owns 1,346,676 shares of the company valued at $2,828,000 after purchasing an additional 637,165 shares during the period. Finally, Marshall Wace LLP acquired a new position in shares of AquaBounty Technologies in the fourth quarter worth approximately $986,000. 52.94% of the shares are currently held by institutional investors and hedge funds.
AquaBounty Technologies Company Profile (Get a rating)
AquaBounty Technologies, Inc, a biotechnology company, is focused on improving productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetics, genomics and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bio-engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon roe, fingerlings and by-products.
This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Should you invest $1,000 in AquaBounty Technologies right now?
Before you consider AquaBounty Technologies, you’ll want to hear this.
MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and AquaBounty Technologies didn’t make the list.
While AquaBounty Technologies currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the 5 actions here